Varinder S Athwal (Varinder Athwal)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Topics

Extracellular Matrix

Top Venues

Scientific reports

Alimentary pharmacology & therapeutics

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Elliot J Jokl, Jessica Llewellyn, Kara Simpson, Oluwatobi Adegboye, James Pritchett, Leo Zeef, Ian J Donaldson, Varinder S Athwal, Huw Purssell, Oliver Street, Lucy Bennett, Indra Neil Guha, Neil A Hanley, Qing-Jun Meng, Karen Piper Hanley, null null
Circadian Disruption Primes Myofibroblasts for Accelerated Activation as a Mechanism Underpinning Fibrotic Progression in Non-Alcoholic Fatty Liver Disease. Cells 12 (12) (2023)
Huw Purssell, Lucy Bennett, Oliver Street, Karen Piper Hanley, Neil A Hanley, Dipesh H Vasant, Varinder S Athwal
The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study. Scientific reports 13 (1) (2023)
Elliot J Jokl, Jessica Llewellyn, Kara Simpson, Oluwatobi Adegboye, James Pritchett, Leo Zeef, Ian J Donaldson, Varinder S Athwal, Huw Purssell, Oliver Street, Lucy Bennett, Indra Neil Guha, Neil A Hanley, Qing-Jun Meng, Karen Piper Hanley, null null
Circadian Disruption Primes Myofibroblasts for Accelerated Activation as a Mechanism Underpinning Fibrotic Progression in Non-Alcoholic Fatty Liver Disease. Cells 12 (12) (2023)
Elliot J Jokl, Jessica Llewellyn, Kara Simpson, Oluwatobi Adegboye, James Pritchett, Leo Zeef, Ian J Donaldson, Varinder S Athwal, Huw Purssell, Oliver Street, Lucy Bennett, Indra Neil Guha, Neil A Hanley, Qing-Jun Meng, Karen Piper Hanley, null null
Circadian Disruption Primes Myofibroblasts for Accelerated Activation as a Mechanism Underpinning Fibrotic Progression in Non-Alcoholic Fatty Liver Disease. Cells 12 (12) (2023)
Jennifer Scott, Andrew M Jones, Karen Piper Hanley, Varinder S Athwal
Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis. Alimentary pharmacology & therapeutics 55 (4) (2022)
Eman El-Khateeb, Adam S Darwich, Brahim Achour, Varinder S Athwal, Amin Rostami-Hodjegan
Review article: time to revisit Child-Pugh score as the basis for predicting drug clearance in hepatic impairment. Alimentary pharmacology & therapeutics 54 (4) (2021)
Sayyid Raza, Elliot J Jokl, James Pritchett, Katherine Martin, Kim Su, Kara Simpson, Lindsay Birchall, Aoibheann F Mullan, Varinder S Athwal, Daniel T Doherty, Leo A H Zeef, Neil Cowan Henderson, Philip A Kalra, Neil A Hanley, Karen Piper Hanley
SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast function. Science signaling 14 (672) (2021)
Eman El-Khateeb, Brahim Achour, Daniel Scotcher, Zubida M Al-Majdoub, Varinder S Athwal, Jill Barber, Amin Rostami-Hodjegan
Scaling Factors for Clearance in Adult Liver Cirrhosis. Drug metabolism and disposition: the biological fate of chemicals 48 (12) (2020)
Varinder S Athwal, James Pritchett, Katherine Martin, Jessica Llewellyn, Jennifer Scott, Emma Harvey, Abed M Zaitoun, Aoibheann F Mullan, Leo A H Zeef, Scott L Friedman, William L Irving, Neil A Hanley, Indra Neil Guha, Karen Piper Hanley
Publisher Correction: SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis. Scientific reports 9 (1) (2019)
Ruth Tunney, Jennifer Scott, Velauthan Rudralingam, Sue Liong, Varinder S Athwal
Secondary sclerosing cholangitis following extracorporeal membrane oxygenation for acute respiratory distress in polytrauma. Clinical case reports 6 (9) (2018)
Varinder S Athwal, James Pritchett, Katherine Martin, Jessica Llewellyn, Jennifer Scott, Emma Harvey, Abed M Zaitoun, Aoibheann F Mullan, Leo A H Zeef, Scott L Friedman, William L Irving, Neil A Hanley, Indra Neil Guha, Karen Piper Hanley
SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis. Scientific reports 8 (1) (2018)